Proteomics

Dataset Information

0

HDL functionality is dependent on hepatocyte stress defense factors NRF1 and NRF2


ABSTRACT: High density lipoproteins (HDL) promote homeostasis and counteract stressful tissue damage that underlie cardiovascular and other diseases by mediating reverse cholesterol transport, reducing inflammation, and abrogating oxidative damage. However, metabolically stressful conditions associated with atherosclerosis can impair these effects. Hepatocytes play a major role in the genesis and maturation of circulating HDL. Liver stress elicits marked regulatory changes to circulating HDL abundance and composition, which affect its functionality. Mechanisms linking liver stress to HDL functionality are incompletely understood. In this study, we sought to determine whether stress defending transcription factors nuclear factor erythroid 2 related factor-1 (NRF1) and -2 (NRF2) promote hepatocyte production of functional HDL. Using genetically engineered mouse models briefly fed a mild metabolically stressful diet, we investigated the effect of hepatocyte-specific deletion of NRF1, NRF2, or both on circulating HDL cholesterol level, protein composition, and function. Combined deletion, but not single gene deletion, reduced HDL cholesterol content as well as the capacity of HDL to accept cholesterol efflux from cultured macrophages and to counteract tumor necrosis factor a-induced inflammatory effect on cultured endothelial cells. This coincided with substantial alteration to the circulating HDL proteome, which correlated with liver gene expression profiles of corresponding proteins. Altogether, our findings show complementary actions by hepatocyte NRF1 and NRF2 play a role in shaping HDL composition and promote production of functionally viable HDL. Consequently, our study illuminates the possibility that enhancing stress defense programming in the liver may improve atheroprotective and perhaps other health promoting actions of HDL.

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Hepatocyte, Liver

DISEASE(S): Cardiovascular System Disease

SUBMITTER: Sadhna Phanse  

LAB HEAD: Scott Widenmaier, PhD

PROVIDER: PXD042103 | Pride | 2023-07-03

REPOSITORIES: Pride

Similar Datasets

2023-03-22 | PXD032069 | Pride
2012-05-17 | E-GEOD-35124 | biostudies-arrayexpress
2021-02-11 | PXD023471 | Pride
2012-05-18 | GSE35124 | GEO
2021-01-31 | GSE164517 | GEO
2017-11-30 | GSE103949 | GEO
2022-10-24 | GSE206278 | GEO
2021-10-06 | GSE167983 | GEO
2019-01-25 | GSE117855 | GEO
2012-06-30 | E-GEOD-37902 | biostudies-arrayexpress